Navigation Links
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Date:7/19/2009

care, versus placebo plus standard of care, in serologically active (i.e., autoantibody-positive) patients with SLE. This is the largest clinical trial program ever conducted in lupus patients. BLISS-52 randomized and treated 865 patients at 90 clinical sites in 13 countries, primarily in Asia, South America and Eastern Europe. BLISS-76 enrolled and randomized 826 patients at 133 clinical sites in 19 countries, primarily in North America and Europe. The design of the two trials is similar, but the duration of therapy in the two studies is different - 52 weeks for BLISS-52 and 76 weeks for BLISS-76. The data from BLISS-76 will be analyzed after 52 weeks in support of a potential Biologics License Application in the United States and Marketing Authorization Application in Europe and other regions. HGS designed the Phase 3 program for belimumab in collaboration with GSK and leading international SLE experts, and the program is being conducted under a Special Protocol Assessment agreement with FDA.

The primary efficacy endpoint of BLISS-52 and BLISS-76 is the patient response rate at Week 52, as defined by: (1) a reduction from baseline of at least 4 points on the SELENA SLEDAI disease activity scale (which indicates a clinically important reduction in SLE disease activity); (2) no worsening of disease as measured by the Physician's Global Assessment (worsening defined as an increase of 0.30 points or more from baseline); and (3) no new BILAG A organ domain score (which indicates a severe flare of lupus disease activity) and no more than one new BILAG B organ domain score (which would indicate a moderate flare of disease activity). Analysis for the primary endpoint is based on intention-to-treat (ITT) and adjusted for baseline stratification factors, including SELENA SLEDAI score, proteinuria and race.

In each of the two Phase 3 trials, patients were randomized to one of three treatment groups: 10 mg/kg belimumab (BLISS-52
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Aug. 30 The rate of electronic health record ... the next two to five years due to a ... provided by the U.S. government,s HITECH program have also ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... Memorial Hospital—a not-for-profit, 108-bed hospital in Eden, N.C.—has ... through real-time clinical surveillance and instant access to ... award-winning mobile data system, gathers clinical data from ... patient data to any caregiver at the point-of ...
Cached Medicine Technology:U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 2U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 3Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus 2
(Date:4/24/2014)... and health maps at a fine scale across England ... Area Health Statistics Unit (SAHSU), part of the MRC-PHE ... London, the open-access atlas allows researchers, policy makers and ... of 14 diseases and conditions such as lung cancer, ... Alongside this it provides maps of geographical variations of ...
(Date:4/24/2014)... Orange, NJ. April 24, 2014. Nancy Chiaravalloti, PhD, ... by Saint Peter,s University in Jersey City, New Jersey. ... University,s Pope Lecture Hall on the topic of "Treating ... "It is an honor to be a part of ... Saint Peter,s University," said Dr. Chiaravalloti. "The field of ...
(Date:4/24/2014)... since it was first identified more than 15 years ... an integral role in preventing the onset and progression ... or mutated, malignant cells can grow unchecked and cancer ... at Beth Israel Deaconess Medical Center (BIDMC) helps explain ... how its loss or alteration can set cells on ...
(Date:4/24/2014)... giving scientists a better understanding of drug interactions, which ... , When two or more medications are taken ... the effectiveness of the other. Similarly, one drug ... interactions are a major cause of illness and hospitalization. ... practical scope of drug studies in humans. Limits ...
(Date:4/24/2014)... often coexist with the negative and stressful outcomes for ... diagnosed with a life-limiting illness, says a recent study ... , While the challenges are numerous and life-changing and ... participated in the Waterloo-led research reported positive outcomes as ... appear in the most recent issue of the ...
Breaking Medicine News(10 mins):Health News:New high-detail atlas offers tool to explore local environment and health 2Health News:New high-detail atlas offers tool to explore local environment and health 3Health News:Kessler Foundation scientist named 63rd Mendel Lecturer by St. Peter's University 2Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Parents of severely ill children see benefits as caregivers, says study 2
... officials desire quick-response emergency capability to treat ... suspected and known cyanide poisoning ... today announced that the,Florida Department of Health, Office of ... for Cyanide,Poisoning in the State,s emergency medical service (EMS) ...
... Physiology and Exercise Metabolism (Montana WPEM) will present a ... American College of Sports Medicine, showing that wildland ... supplement, Wellmune WGP, had far fewer 23 ... similar group of firefighters taking a placebo. , Montana ...
... Italy, 29 May 2008 - Patients suffering from hemineglect ... to their left side. However, sometimes these ignored stimuli ... in the May 2008 issue of Cortex, Jerome Sackur ... reported that unconscious processing in hemineglect is not limited ...
... Amerifit Brands Educates Consumers about Urinary Health, CROMWELL, Conn., ... tract infections (UTIs) are the second most common type,of infection ... doctor visits,each year. One-third of women will be diagnosed with ... women will get at least one in their lifetime.(2),However, many ...
... BOSTON, May 29 The Global Business and ... senior business,executives and clinical scientific leaders, will host a ... The forum is the third,in a series of four ... well being of employees and their families., The ...
... beer, liquor had opposite effect , , THURSDAY, May 29 ... may not only be safe for the liver, but ... disease (NAFLD), according to a new study that challenges ... the University of California, San Diego, included 7,211 nondrinkers ...
Cached Medicine News:Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 2Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 3Health News:Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study 2Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 2Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 3Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 4Health News:Daily Glass of Wine Cut Risk of Fatty Liver Disease 2
... Multi frequency and multigate ... detection and fitted with ... tests for hemodynamic evaluation. ... as well for routine ...
The Spencer Technologies PMD 100 (TCD 100M) is the worlds first stand-alone digital transcranial doppler system....
Swiss Watchmaker Forceps, 4" extra-long precision ground points....
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
Medicine Products: